This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Will Cinemark Holdings (CNK) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Cinemark (CNK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ROKU's Q1 Loss Narrower Than Expected, Revenues Increase Y/Y
by Zacks Equity Research
ROKU's first-quarter 2023 results benefit from growing active accounts and streaming hours on The Roku Channel.
IMAX and Megarama Expand Partnership for Three New Locations
by Zacks Equity Research
IMAX announces the enhancement of its partnership with Megarama for three new locations in France and Morocco.
Fast-paced Momentum Stock Cinemark (CNK) Is Still Trading at a Bargain
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Cinemark (CNK) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Cinemark (CNK) Surges 6.6%: Is This an Indication of Further Gains?
by Zacks Equity Research
Cinemark (CNK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Cinemark Holdings (CNK) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Cinemark (CNK) delivered earnings and revenue surprises of -141.18% and 5.50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
AMC Entertainment (AMC) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
by Zacks Equity Research
AMC Entertainment (AMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Cinemark Holdings (CNK) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Cinemark (CNK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
RICK vs. CNK: Which Stock Is the Better Value Option?
by Zacks Equity Research
RICK vs. CNK: Which Stock Is the Better Value Option?
Cinemark Holdings (CNK) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Cinemark (CNK) delivered earnings and revenue surprises of 4.76% and 5.55%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
OneSpaWorld (OSW) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
OneSpaWorld (OSW) delivered earnings and revenue surprises of 116.67% and 21.16%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Will AMC Entertainment (AMC) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
AMC Entertainment (AMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cinemark Holdings (CNK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Cinemark (CNK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include JDefinitive Healthcare, Cinemark Holdings, MeridianLink and Spirit AeroSystems
by Zacks Equity Research
JDefinitive Healthcare, Cinemark Holdings, MeridianLink and Spirit AeroSystems are part of Zacks Screen of the Week article.
4 Toxic Stocks That May Give You a Tough Time
by Rimmi Singhi
Accurately identifying toxic stocks and getting rid of them at the right time can protect your portfolio. It's time to cut ties with toxic stocks like DH, CNK, MLNK and SPR.
Distance Yourself From These 4 Toxic Stocks to Ward Off Losses
by Rimmi Singhi
It's time to cut ties with toxic stocks including CNK, LVS, TNDM and HCI to safeguard your portfolio.
Cinemark Holdings (CNK) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Cinemark (CNK) delivered earnings and revenue surprises of 30.77% and 2.06%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Planet Fitness (PLNT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Planet Fitness (PLNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cinemark Holdings (CNK) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Cinemark (CNK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Implied Volatility Surging for Cinemark (CNK) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Cinemark (CNK) stock based on the movements in the options market lately.
Are Options Traders Betting on a Big Move in Cinemark (CNK) Stock?
by Zacks Equity Research
Investors need to pay close attention to Cinemark (CNK) stock based on the movements in the options market lately.
Cinemark Holdings (CNK) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Cinemark (CNK) delivered earnings and revenue surprises of -1.64% and 3.96%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
SeaWorld (SEAS) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
SeaWorld (SEAS) delivered earnings and revenue surprises of 20% and 3.42%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Will Cinemark Holdings (CNK) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Cinemark (CNK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
RICK or CNK: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
RICK vs. CNK: Which Stock Is the Better Value Option?